mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.6 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |